1. 癌症、心脑血管、呼吸和代谢性疾病防治研究国家科技重大专项:呼吸和共病流行状况、发生发展机制与防治策略研究(项目负责人),项目编号:2023ZD0506000,2024.08月-2028.07,1774.10 万元。科技创新2030
2. 国自然医学部面上项目:miRNA调控缺氧诱导因子HIF3A在慢阻肺氧化应激铁死亡途径中的作用机制研究(第一申请人),项目编号:8227010650,2023.01.01-2026.12.31,74.81万元。
3. 中国医学科学院医学与健康科技创新工程:重大慢性呼吸系统疾病早期精准评估与全程综合干预研究(首席专家),项目编号:2021-I2M-1-049,2021.10-2025.12。7000万元。
4. 国家自然科学基金区域创新发展联合基金:蛋白质翻译后修饰调控巨噬细胞稳态在高原地区慢性阻塞性肺疾病始 动与演进中的作用与机制研究(项目负责人),项目编号:U24A20644,2025.01-2028.10。260万元。
Jiang J, Zheng Z, Chen S, Liu J, Jia J, Huang Y, Liu Q, Cheung CY, Sin DD,Yang T(共同通讯作者), Wang C. Hypoxia inducible factor (HIF) 3α prevents COPD by inhibitingalveolar epithelial cell ferroptosis via the HIF-3α-GPx4 axis. Theranostics.2024 Aug 28;14(14):5512-5527.
Wang C, Qi W, Yang T(共同第一作者、共同通讯作者), Jiao L, Chen Q, Huang K, Yu F, Geldsetzer P,Bärnighausen T, Chen S. The care cascade of chronic obstructive pulmonary disease in China: a cross-sectional study of individual-level data at enrolment into the national 'Happy Breathing' Programme. EClinicalMedicine. 2024 Jul 16;74:102597.
Niu Y, Niu H, Meng X, Zhu Y, Ren X, He R, Wu H, Yu T, Zhang Y, Kan H, Chen R,Yang T(通讯作者), Wang C. Associations Between Air Pollution and the Onset of Acute Exacerbations of COPD: A Time-Stratified Case-Crossover Study in China. Chest. 2024 Jun 19:S0012-3692(24)00745-1.
Chen Q, Fan Y, Huang K, Li W, Geldsetzer P, Bärnighausen T, Yang T(共同通讯作者), Wang C,Chen S. Cost-effectiveness of population-based screening for chronic obstructive pulmonary disease in China: a simulation modeling study. Lancet Reg Health West Pac. 2024 Apr 29;46:101065.
Duan R, Huang K, Yu T, Chang C, Chu X, Huang Y, Zheng Z, Ma L, Li B, Yang T(通讯作者). Interleukin-2/anti-interleukin-2 complex attenuates inflammation in a mouse COPD model by expanding CD4+ CD25+ Foxp3+ regulatory T cells. Int Immunopharmacol. 2024 Apr 20;131:111849.
Huang K, Han X, Pan Z, Xu J, Zhao J, Zhang X, Song Y, Kang J, Ran P, Zhou Y, Shen H, Wen F, Huang K, Chen Y, Guo Y, Shan G, Wu S, Guan T, Yang (共同通讯作者)T, Wang C. Impact of Using Pre- and Postbronchodilator Spirometry Reference Values in a Chinese Population. Am J Respir Crit Care Med. 2024 Oct 1;210(7):881-889.
Chang C, Huang K, Xu X, Duan R, Yu T, Chu X, Chen C, Li B, Yang T(共同通讯作者). MiR-23a-5p alleviates chronic obstructive pulmonary disease through targeted regulation of RAGE-ROS pathway. Respir Res. 2024 Feb 20;25(1):93.
Huang K, Zheng Z, Li W, Niu H, Lei J, Dong F, Yang T(共同通讯作者), Wang C.Sociodemographic correlates with prevalence of comorbidities in patients with chronic obstructive pulmonary disease: a study from a Chinese National Survey. Lancet Reg Health West Pac. 2023 Oct 13;42:100937.
Lei J, Huang K, Wu S, Xu J, Xu Y, Zhao J, Zhang X, Bai C, Song Y, Kang J, Ran P, Zhou Y, Shen H, Wen F, Huang K, Chen Y, Yao W, Sun T, Lin Y, Zhu J, Shan G, Yang T(共同通讯作者), Wang C; China Pulmonary Health (CPH) Study Investigators. Heterogeneities and impact profiles of early chronic obstructive pulmonary disease status: findings from the China Pulmonary Health Study. Lancet Reg Health West Pac. 2024 Feb 6;45:101021.
Chang C, He F, Ao M, Chen J, Yu T, Li W, Li B, Fang M, Yang T(通讯作者). Inhibition of Nur77 expression and translocation by compound B6 reduces ER stress and alleviates cigarette smoke-induced inflammation and injury in bronchial epithelial cells. Front Pharmacol. 2023 Jun 19;14:1200110.